IP Library Granted Patent US 8,524,878
Granted Patent B1
US 8,524,878 · App. 13/190,955 · Granted Sep 3, 2013

Methods of identifying an organism

Inventors: Emily B. Zentz (Germantown, MD); Colin William Dykes (Albuquerque, NM); Adam Michael Briska (Madison, WI)
Assignee: OpGen, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,524,878
App. No.
13/190,955
Granted
Sep 3, 2013
Kind
B1
Abstract

This disclosure features methods of identifying an organism. In certain embodiments, the invention provides methods of distinguishing virulent and non-virulent strains of Listeria monocytogenes.

Claims (11)

1. A method of distinguishing virulent and low- or non-violent strains of Listeria monocytogenes , the method comprising:

obtaining a nucleic acid from L. monocytogenes;

preparing an optical map of one or more restriction digests of the obtained nucleic acid; and

detecting an insertion that is at least 48.3 kb in size in a clpP gene of a genome of L. monocytogenes , wherein presence of the insertion is indicative of a low- or non-virulent strain of L. monocytogenes.

2. The method according to claim 1 , wherein the nucleic acid is obtained from at least one sample type selected from the group consisting of: a food sample, an environmental sample, and a human tissue or body fluid sample.

3. The method according to claim 2 , wherein the environmental sample is selected from the group consisting of water, soil, sewage, and decaying vegetable matter.

4. The method according to claim 2 , wherein the tissue or body fluid is from a human having a disease selected from the group consisting of meningitis, gastroenteritis, and septicemia.

5. The method according to claim 1 , wherein the L. monocytogenes is classified as a serotype 4b strain.

6. The method according to claim 1 , wherein the L. monocytogenes is classified as a serotype 1/2a strain.

7. The method according to claim 1 , wherein the L. monocytogenes low- or non-virulent strain is selected from the group consisting of L. monocytogenes BO43 or L. monocytogenes 416.

8. The method according to claim 1 , wherein the L. monocytogenes virulent strain is selected from the group consisting of L. monocytogenes strain 4b F2365 , L. monocytogenes strain EGD-e, L. monocytogenes strain A23 , L. monocytogenes Clip81459 ‘4b CLIP80459’.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Feb 3, 2021
From: MERCK GLOBAL HEALTH INNOVATION FUND, LLC
To: OPGEN, INC.; ADVANDX, INC.
Reel/Frame 055209/0242 →
SECURITY INTEREST Recorded Aug 17, 2015
From: OPGEN, INC.; ADVANDX, INC.
To: MERCK GLOBAL HEALTH INNOVATION FUND, LLC
Reel/Frame 036377/0129 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 14, 2011
From: ZENTZ, EMILY B.; DYKES, COLIN WILLIAM; BRISKA, ADAM MICHAEL
To: OPGEN, INC.
Reel/Frame 026904/0611 →
Continuity (2)
Continuation In Part 12120586 · May 14, 2008
Provisional Application 61029816 · Feb 19, 2008